scispace - formally typeset
D

Dong Zhang

Researcher at New York Institute of Technology

Publications -  28
Citations -  2454

Dong Zhang is an academic researcher from New York Institute of Technology. The author has contributed to research in topics: DNA damage & DNA repair. The author has an hindex of 18, co-authored 28 publications receiving 2084 citations. Previous affiliations of Dong Zhang include University of South Dakota & Harvard University.

Papers
More filters
Journal ArticleDOI

Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

TL;DR: Phosphopeptide affinity proteomic analysis identified a protein, Abraxas, that directly binds the BRCA1 BRCT repeats through a phospho-Ser-X- X-Phe motif, forming a third type of B RCA1 complex.
Journal ArticleDOI

The ubiquitin-specific protease USP28 is required for MYC stability

TL;DR: The MYC proto-oncogene encodes a transcription factor that has been implicated in the genesis of many human tumours and one of these genes encodes USP28, an ubiquitin-specific protease required for MYC stability in human tumour cells.
Journal ArticleDOI

A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response

TL;DR: It is shown that USP28 is required to stabilize Chk2 and 53BP1 in response to DNA damage, and these studies implicate DNA-damage-induced ubiquitination and deubiquitination as a major regulator of theDNA-damage response for Chk 2, 53BP 1, and a number of other proteins in the DNA- damage checkpoint pathway, including several mediators, such as Mdc1, Claspin, and TopBP1.
Journal ArticleDOI

Identification of eight proteins that cross-link to pre-mRNA in the yeast commitment complex

TL;DR: The results indicate that the 5' splice site region and environs are dense with protein contacts in the commitment complex and suggest that some of them make important contributions to formation or stability of the U1 snRNP-pre-mRNA complex.
Journal ArticleDOI

Cannabidiol (CBD) as a Promising Anti-Cancer Drug

TL;DR: The most recent findings that strongly support the further development of CBD as a promising anti-cancer drug are discussed.